How much does a box of Avonib cost in China?

Ivosidenib is a targeted drug used to treat specific types of cancer, mainly for patients carrying isocitrate dehydrogenase (IDH1) mutations. IDH1Gene mutations are common in certain types of cancer, such as acute myeloid leukemia (AML) and certain solid tumors. Ivonib inhibits the activity of IDH1 enzyme and blocks the abnormal metabolic pathways of cancer cells, thereby inhibiting the growth and spread of tumors.

Avosidenib is currently on the market in China, but it is not included in medical insurance. The price is as high as about 30,000 to 40,000 yuan. Please consult the local hospital pharmacy for specific prices. The cheaper ones abroad are mainly Laotian generic drugs. The price is around 6,000 to 7,000 yuan, which is much cheaper than domestic drugs, and the ingredients of the drugs are basically the same.

The main indication of ivonib isIDH1 mutated acute myeloid leukemia, especially for those patients who are not suitable for conventional chemotherapy or have developed resistance to traditional treatment. In addition, ivosidenib is also used to treat other cancers such as relapsed or refractory cholangiocarcinoma, although these applications are still under investigation.

Avosidenib is usually administered in oral form, and patients need to take it on time every day to ensure the continued effect of the drug in the body. Drug metabolism is mainly completed by the liver, so patients with hepatic insufficiency need to pay special attention when using this drug. Common side effects include fatigue, nausea, diarrhea, joint pain, and leukopenia. Because ivonib can cause serious side effects, such as differentiation syndrome and QT prolongation, patients need to be monitored regularly during treatment.

The launch of ivosidenib provides a new treatment option for cancer patients carryingIDH1 mutations, especially those who fail to respond to traditional treatments. However, due to its higher price and treatment effects that vary from person to person, patients should fully discuss with their doctor before use to determine whether the treatment plan is suitable for them.